lobbying_activities: 1083426

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1083426	87447146-af02-4b0c-ba38-f4b25b567de3	Q1	AMERICAN SOCIETY OF HEMATOLOGY	59171	AMERICAN SOCIETY OF HEMATOLOGY	2011	first_quarter	MED	H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Nuclear Regulatory Commission (NRC),SENATE		30000	0	0	2011-04-19T09:26:33.130000-04:00